Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz SafiledCriticalSandoz Sa
Publication of BE898873ApublicationCriticalpatent/BE898873A/fr
C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
C07D457/12—Nitrogen atoms
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
La présente invention a pour objet 1a N,N-diéthyl-N'- ((8 alpha)-1-éthyl-6-méthyl-ergoline-8-yl)-sulfamide et la N,N-diéthyl-N'-((8 alpha)-1-isopropyl-6-méthyl-ergoline-8-yl)-sulfamide (I). Ces composés peuvent etre utilisés comme médicaments, en particulier comme agents anti-parkinsoniens, comme inhibiteurs de la sécrétion de la prolactine, et comme agents anti-dépresseurs.
BE1/10956A1983-02-161984-02-10Nouveaux derives de l'acide lysergique, leur preparation et leur utilisation comme medicaments
BE898873A
(fr)
New derivatives of 2-azabicyclo(2,2,2)octane-3-carboxylic acid,process for their preparation,agents containing these derivatives and the use thereof,and of 2-azabicyclo(2,2,2)octane-3-carboxylic acid,as an intermediate stage and process for the preparation thereof
Preparation of 16-phenoxy-and 16-substituted phenoxy-4,5,13-prostatrienoic acid derivatives,some such novel compounds and pharmaceutical compositions containing them